Hou Xiaohong, Yang Wengang, Zhao Yongsen, Agarwal Atul, Huang Mingjun
Antiviral Drug Discovery, Achillion Pharmaceuticals, Inc., New Haven, CT 06511, USA.
Virology. 2009 Jan 20;383(2):271-8. doi: 10.1016/j.virol.2008.10.037. Epub 2008 Nov 25.
Despite being the focus of intensive investigation for its enzymatic activities and its roles in HCV virus replication, little is known about the internal processing of NS3. Here we show that single mutations at P1 position of the NS3/4A junction lead to alternative cleavages. Among the multiple novel cleavage products observed, there were two predominant species of about 12 kDa (p12) and 67 kDa (p67). This p12 species consists of the NS4A and about a 6 kDa long C-terminal region of NS3 and forms a complex with NS3. The remaining NS3 corresponds to the p67 species. This alternative cleavage is an NS3 protease-mediated intra-molecular event and more interestingly can also be induced with low concentrations of one NS3 protease inhibitor examined. Our results led us to propose a model explaining the alternative cleavage observed and its functional role.
尽管NS3的酶活性及其在丙型肝炎病毒(HCV)复制中的作用一直是深入研究的焦点,但对NS3的内部加工过程却知之甚少。在此我们表明,NS3/4A连接处P1位置的单突变会导致不同的切割方式。在观察到的多种新型切割产物中,有两种主要的产物,分别约为12 kDa(p12)和67 kDa(p67)。这种p12产物由NS4A和NS3约6 kDa长的C末端区域组成,并与NS3形成复合物。其余的NS3则对应于p67产物。这种不同的切割是由NS3蛋白酶介导的分子内事件,更有趣的是,在所检测的一种NS3蛋白酶抑制剂的低浓度情况下也能诱导这种切割。我们的结果使我们提出了一个模型,用以解释所观察到的不同切割及其功能作用。